These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2863097)

  • 1. Sulfasalazine-induced pulmonary disease.
    Moseley RH; Barwick KW; Dobuler K; DeLuca VA
    Dig Dis Sci; 1985 Sep; 30(9):901-4. PubMed ID: 2863097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S; Matsumoto K; Kitagawa T; Yamamoto J
    Am J Gastroenterol; 1992 Nov; 87(11):1654-7. PubMed ID: 1359782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathological changes in lungs and liver after therapy of ulcerative colitis].
    Matek W; Rösch W; Becker V
    Fortschr Med; 1980 Apr; 98(13):491-6. PubMed ID: 6102956
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulfasalazine pneumonitis.
    Averbuch M; Halpern Z; Hallak A; Topilsky M; Levo Y
    Am J Gastroenterol; 1985 May; 80(5):343-5. PubMed ID: 2859799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tubular-interstitial nephritis and fibrosing alveolitis induced by sulfasalazine in ulcerative colitis].
    Avdeev VG; Fomin VV; Popova EN; Iurkevich LIu; Osipenko VI; Sokolina IA; Popova IA
    Ter Arkh; 2006; 78(1):77-9. PubMed ID: 16512452
    [No Abstract]   [Full Text] [Related]  

  • 6. Desquamative interstitial pneumonitis complicating inflammatory bowel disease of childhood.
    Teague WG; Sutphen JL; Fechner RE
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):663-7. PubMed ID: 2863342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of recovery of lung function in sulphasalazine-induced alveolitis.
    Moss SF; Ind PW
    Respir Med; 1991 Jan; 85(1):73-5. PubMed ID: 1673035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy.
    Williams T; Eidus L; Thomas P
    Chest; 1982 Jun; 81(6):766-8. PubMed ID: 6122540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial pneumonia due to sulfasalazine.
    Sigvaldason A; Sörenson S
    Eur J Respir Dis; 1983 Apr; 64(3):229-33. PubMed ID: 6132833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.
    Sullivan SN
    J Clin Gastroenterol; 1987 Aug; 9(4):461-3. PubMed ID: 2888803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosing alveolitis and treatment with sulphasalazine.
    Davies D; MacFarlane A
    Gut; 1974 Mar; 15(3):185-8. PubMed ID: 4152289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine-induced lupus erythematosus.
    Clementz GL; Dolin BJ
    Am J Med; 1988 Mar; 84(3 Pt 1):535-8. PubMed ID: 2894766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphasalazine-induced reversible hypersensitivity pneumonitis and fatal fibrosing alveolitis: report of two cases.
    Leino R; Liippo K; Ekfors T
    J Intern Med; 1991 Jun; 229(6):553-6. PubMed ID: 1675246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Sulphasalazine-induced lung disease.
    Lancet; 1974 Aug; 2(7879):504-5. PubMed ID: 4136679
    [No Abstract]   [Full Text] [Related]  

  • 16. Serious complications of sulfasalazine.
    Pearl RK; Nelson RL; Prasad ML; Orsay CP; Abcarian H
    Dis Colon Rectum; 1986 Mar; 29(3):201-2. PubMed ID: 2867862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.
    Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA
    Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: a case report and review of literature.
    Yamakado S; Yoshida Y; Yamada T; Kishida T; Kobayashi M; Nomura T
    Intern Med; 1992 Jan; 31(1):108-13. PubMed ID: 1348965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis.
    McKee AL; Rajapaksa A; Kalish PE; Pitchumoni CS
    Am J Gastroenterol; 1983 Feb; 78(2):86-9. PubMed ID: 6130700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.